Abstract:Adeno-associated virus (AAV) is the preferred vector for gene therapy of hereditary deafness, and different viral serotypes, promoters and transduction pathways can influence the targeting of AAV to different types of cells and the expression levels of numerous exogenous genes. To determine the transduction and expression patterns of AAV with different serotypes or promoters in hair cells and supporting cells in the neonatal mouse cochlea, we examined the expression of enhanced green fluorescent protein (eGFP) for five different types of AAV vectors [serotypes 2, 9, and Anc80L65 with promoter cytomegalovirus (CMV)-beta-Globin and serotypes 2 and 9 with promoter chicken beta-actin (CBA)] in in vitro cochlear explant cultures and we tested the transduction of AAV2/2-CBA, AAV2/9-CBA, and AAV2/Anc80L65-CMV by in vivo microinjection into the scala media of the cochlea. We found that each AAV vector had its own transduction and expression characteristics in hair cells and supporting cells in different regions of the cochlea. There was a tonotopic gradient for the in vitro transduction of AAV2/2-CBA, AAV2/9-CBA, AAV2/2-CMV, and AAV2/9-CMV in outer hair cells (OHCs), with more OHCs expressing eGFP at the base of the cochlea than at the apex. AAV2/2-CBA in vitro and AAV2/Anc80L65-CMV in vivo induced more supporting cells expressing eGFP at the apex than in the base. We found that AAV vectors with different promoters had different expression efficacies in hair cells and supporting cells of the auditory epithelium. The CMV-beta-Globin promoter could drive the expression of the delivered construct more efficiently in hair cells, while the CBA promoter was more efficient in supporting cells. The in vitro and in vivo experiments both demonstrated that AAV2/Anc80L65-CMV was a very promising vector for gene therapy of deafness because of its high transduction rates in hair cells. These results might be useful for selecting the appropriate vectors for gene delivery into different types of inner ear cells and thus improving the effectiveness of gene therapy.

Adeno-Associated Viral Vector-Mediated Expression of Nt4-Adnf-9 Fusion Gene Protects Against Aminoglycoside-Induced Auditory Hair Cell Loss in Vitro

Targeted Retrograde Transfection of Adenovirus Vector Carrying Brain-Derived Neurotrophic Factor Gene Prevents Loss of Mouse (twy/twy) Anterior Horn Neurons in Vivo Sustaining Mechanical Compression.

Therapeutic Effect of Adeno-Associated Virus (Aav)-Mediated Adnf-9 Expression on Cochlea of Kanamycin-Deafened Guinea Pigs

Treatment of adeno-associated virus mediated ADNF-9 gene transfection on guinea pig cochlea deafened by kanamycin

Protection Against Aminoglycoside-induced Ototoxicity by Regulated AAV Vector-mediated GDNF Gene Transfer into the Cochlea.

Protection Against Aminoglycoside-induced Ototoxicity by Regulated AAV Vector|[ndash]|mediated GDNF Gene Transfer Into the Cochlea

663. Protection Against Aminoglycoside-Induced Ototoxicity by AAV Vector-Mediated GDNF Gene Transfer into the Cochlea

[Experimental Study on Embryonic Neural Stem Cells Transplantation into Natural Rat Cochlea Via Round Window].

Effects of Adeno-Associated Virus Vector-Mediated GDNF Gene Transfer on Kanamycin-Induced Cochlear Toxicity

Study on neural stem cell transplantation into natural rat cochlea via round window.

Construction of Prokaryotic Expression Vector for Pbv220/nt4–adnf–9

AAV-mediated NT-3 Overexpression Protects Cochleae Against Noise-Induced Synaptopathy.

[Recombinate Adeno-Associated Virus Raav-Nt4-adnf-9 Transfects to the Cultured Cochleae of Rats in Vitro].

Transduction of Adeno-Associated Virus Vectors Targeting Hair Cells and Supporting Cells in the Neonatal Mouse Cochlea

Adeno-associated Virus-Mediated Bcl-xL Prevents Aminoglycoside-Induced Hearing Loss in Mice

Delivery of Adeno-Associated Virus Vectors in Adult Mammalian Inner-Ear Cell Subtypes Without Auditory Dysfunction

Specific and Efficient Transduction of Cochlear Inner Hair Cells with Recombinant Adeno-Associated Virus Type 3 Vector

Gene Therapy with Adeno-Associated Virus Vector-Mediated Extracellular Superoxide Dismutase Attenuates Kanamycin-induced Cochlear Damage

Early postnatal virus inoculation into the scala media achieved extensive expression of exogenous green fluorescent protein in the inner ear and preserved auditory brainstem response thresholds.

AAV-ie-K558R mediated cochlear gene therapy and hair cell regeneration

Hair Cell Regeneration after ATOH1 Gene Therapy in the Cochlea of Profoundly Deaf Adult Guinea Pigs